Terms: = Lung cancer AND AXIN2, AXIL, 8313, ENSG00000168646, MGC126582, DKFZp781B0869
56 results:
1. Pan-cancer analysis reveals the characteristics and roles of tooth agenesis mutant genes.
Liu Y; Yang J; Li X; Chen S; Zhu C; Shi Y; Dang S; Zhang W; Li W
Medicine (Baltimore); 2023 Dec; 102(50):e36001. PubMed ID: 38115305
[TBL] [Abstract] [Full Text] [Related]
2. Pancreatic stellate cell-derived exosomal tRF-19-PNR8YPJZ promotes proliferation and mobility of pancreatic cancer through axin2.
Cao W; Dai S; Ruan W; Long T; Zeng Z; Lei S
J Cell Mol Med; 2023 Sep; 27(17):2533-2546. PubMed ID: 37488774
[TBL] [Abstract] [Full Text] [Related]
3. Aggressive progression to EGFR tyrosine kinase inhibitors in advanced NSCLC patients: concomitant mutations, prognostic indicator and subsequent management.
Wen R; Chen Y; Long J; Huang X; Guo Y; Lin B; Yu Z
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8307-8316. PubMed ID: 37074454
[TBL] [Abstract] [Full Text] [Related]
4. Dual Impact of IGF2 on Alveolar Stem Cell Function during Tobacco-Induced Injury Repair and Development of Pulmonary Emphysema and cancer.
Boo HJ; Min HY; Park CS; Park JS; Jeong JY; Lee SY; Kim WY; Lee JW; Oh SR; Park RW; Lee HY
Cancer Res; 2023 Jun; 83(11):1782-1799. PubMed ID: 36971490
[TBL] [Abstract] [Full Text] [Related]
5. Alteration of Cellular Energy Metabolism through LPAR2-axin2 Axis in Gastric cancer.
Ara H; Subedi U; Sharma P; Bhattarai S; Sharma S; Manikandan S; Yu X; Bhuiyan MS; Sun H; Miriyala S; Panchatcharam M
Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551233
[TBL] [Abstract] [Full Text] [Related]
6. Transposon Mutagenesis Reveals RBMS3 Silencing as a Promoter of Malignant Progression of BRAFV600E-Driven lung Tumorigenesis.
Vaishnavi A; Juan J; Jacob M; Stehn C; Gardner EE; Scherzer MT; Schuman S; Van Veen JE; Murphy B; Hackett CS; Dupuy AJ; Chmura SA; van der Weyden L; Newberg JY; Liu A; Mann K; Rust AG; Weiss WA; Kinsey CG; Adams DJ; Grossmann A; Mann MB; McMahon M
Cancer Res; 2022 Nov; 82(22):4261-4273. PubMed ID: 36112789
[TBL] [Abstract] [Full Text] [Related]
7. Detection of Potential Mutated Genes Associated with Common Immunotherapy Biomarkers in Non-Small-Cell lung cancer Patients.
Cao L; Cao Z; Liu H; Liang N; Bing Z; Tian C; Li S
Curr Oncol; 2022 Aug; 29(8):5715-5730. PubMed ID: 36005189
[TBL] [Abstract] [Full Text] [Related]
8. Repurposing clofazimine for malignant pleural mesothelioma treatment - In-vitro assessment of efficacy and mechanism of action.
Parvathaneni V; Chilamakuri R; Kulkarni NS; Wang X; Agarwal S; Gupta V
Life Sci; 2022 Oct; 306():120843. PubMed ID: 35908620
[TBL] [Abstract] [Full Text] [Related]
9. Methylation analysis of APC, axin2, DACT1, RASSF1A and MGMT gene promoters in non-small cell lung cancer.
Paschidis K; Zougros A; Chatziandreou I; Tsikalakis S; Korkolopoulou P; Kavantzas N; Saetta AA
Pathol Res Pract; 2022 Jun; 234():153899. PubMed ID: 35489124
[TBL] [Abstract] [Full Text] [Related]
10. A leukemia-protective germline variant mediates chromatin module formation via transcription factor nucleation.
Llimos G; Gardeux V; Koch U; Kribelbauer JF; Hafner A; Alpern D; Pezoldt J; Litovchenko M; Russeil J; Dainese R; Moia R; Mahmoud AM; Rossi D; Gaidano G; Plass C; Lutsik P; Gerhauser C; Waszak SM; Boettiger A; Radtke F; Deplancke B
Nat Commun; 2022 Apr; 13(1):2042. PubMed ID: 35440565
[TBL] [Abstract] [Full Text] [Related]
11. Gene-gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer.
Rosenberger A; Muttray N; Hung RJ; Christiani DC; Caporaso NE; Liu G; Bojesen SE; Le Marchand L; Albanes D; Aldrich MC; Tardon A; Fernández-Tardón G; Rennert G; Field JK; Davies MPA; Liloglou T; Kiemeney LA; Lazarus P; Wendel B; Haugen A; Zienolddiny S; Lam S; Schabath MB; Andrew AS; Duell EJ; Arnold SM; Goodman GE; Chen C; Doherty JA; Taylor F; Cox A; Woll PJ; Risch A; Muley TR; Johansson M; Brennan P; Landi MT; Shete SS; Amos CI; Bickeböller H;
Eur J Med Res; 2022 Jan; 27(1):14. PubMed ID: 35101137
[TBL] [Abstract] [Full Text] [Related]
12. Novel mutation signatures in the prognosis of EGFR-TKIs targeted therapy for non-small cell lung cancer patients based on the 1000-gene panel sequencing.
Zhang H; Jiang D; Jin H; Cui YZ; Wei SJ; Li Y; Dong Q; Zuo J; Tian CJ; Yan F; Wang XW
Neoplasma; 2022 Mar; 69(2):352-360. PubMed ID: 35081725
[TBL] [Abstract] [Full Text] [Related]
13. Resveratrol induces PD-L1 expression through snail-driven activation of Wnt pathway in lung cancer cells.
Yang M; Li Z; Tao J; Hu H; Li Z; Zhang Z; Cheng F; Sun Y; Zhang Y; Yang J; Wei H; Wu Z
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1101-1113. PubMed ID: 33471184
[TBL] [Abstract] [Full Text] [Related]
14. Are developmentally missing teeth a predictive risk marker of malignant diseases in non-syndromic individuals? A systematic review.
Al-Muzian L; Almuzian M; Mohammed H; Ulhaq A; Keightley AJ
J Orthod; 2021 Sep; 48(3):221-230. PubMed ID: 33455496
[TBL] [Abstract] [Full Text] [Related]
15. Long Noncoding RNA DANCR Activates Wnt/β-Catenin Signaling through MiR-216a Inhibition in Non-Small Cell lung cancer.
Yu JE; Ju JA; Musacchio N; Mathias TJ; Vitolo MI
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33302540
[TBL] [Abstract] [Full Text] [Related]
16. Cinobufagin Suppresses Melanoma Cell Growth by Inhibiting LEF1.
Kim GH; Fang XQ; Lim WJ; Park J; Kang TB; Kim JH; Lim JH
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32933177
[TBL] [Abstract] [Full Text] [Related]
17. Thymoquinone suppresses invasion and metastasis in bladder cancer cells by reversing EMT through the Wnt/β-catenin signaling pathway.
Zhang M; Du H; Wang L; Yue Y; Zhang P; Huang Z; Lv W; Ma J; Shao Q; Ma M; Liang X; Yang T; Wang W; Zeng J; Chen G; Wang X; Fan J
Chem Biol Interact; 2020 Apr; 320():109022. PubMed ID: 32112862
[TBL] [Abstract] [Full Text] [Related]
18. Protein Kinase Cι and Wnt/β-Catenin Signaling: Alternative Pathways to Kras/Trp53-Driven lung Adenocarcinoma.
Yin N; Liu Y; Khoor A; Wang X; Thompson EA; Leitges M; Justilien V; Weems C; Murray NR; Fields AP
Cancer Cell; 2019 Aug; 36(2):156-167.e7. PubMed ID: 31378680
[TBL] [Abstract] [Full Text] [Related]
19. Genes associated with increased brain metastasis risk in non-small cell lung cancer: Comprehensive genomic profiling of 61 resected brain metastases versus primary non-small cell lung cancer (Guangdong Association Study of Thoracic Oncology 1036).
Wang H; Ou Q; Li D; Qin T; Bao H; Hou X; Wang K; Wang F; Deng Q; Liang J; Zheng W; Wu X; Wang X; Shao YW; Mou Y; Chen L
Cancer; 2019 Oct; 125(20):3535-3544. PubMed ID: 31287555
[TBL] [Abstract] [Full Text] [Related]
20. Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling.
Ji P; Zhou Y; Yang Y; Wu J; Zhou H; Quan W; Sun J; Yao Y; Shang A; Gu C; Zeng B; Firrman J; Xiao W; Bals R; Sun Z; Li D
Theranostics; 2019; 9(8):2209-2223. PubMed ID: 31149039
[No Abstract] [Full Text] [Related]
[Next]
